My Cancer Genome mobile app unveils the second generation

My Cancer Genome mobile app unveils the second generation -

My Cancer Genome (MCG), a tool for online medicine precision cancer developed by researchers Vanderbilt- Ingram cancer Center, unveiled a free application for mobile second generation that still provides more information on genetic modifications in different types of cancer and therapies available to treat these changes.
MCG new mobile application is available and regularly presents updated information from the website My Cancer Genome (www.mycancergenome.org), a global resource for medicine genetically informed cancer.
"We know that cancer is not a single homogeneous disease and each patient may have mutations or specific genetic alterations that are best treated with targeted therapies for these changes," said Mia Levy, MD Dr. CIVC co-founder of My Cancer Genome tool. "We launched this new application to provide the latest information on targeted therapies for physicians, patients, researchers and caregivers."
The application extends the information on anti-cancer agents and targeted therapies available in the MCG app drug list which was published in June 2013. The content includes information about various forms of cancer, linked genes cancer, and specific alterations, including genetic mutations and fusions. Content on the mobile app and My Cancer Genome is provided and updated by physicians and physician-scientists from 22 institutions in 10 countries and already covers hundreds of mutations in 19 cancer types.

Users can search by type of cancer, alteration of the gene, drug name (both commercial and experimental), and they can find clinical trials available for patients with these gene alterations. Users can also save favorite searches and pages of interest to stay informed when pages are updated.
The new CWM application has been redesigned to accommodate an iPad tablet up and is available for iPhone and iPad at no charge in the iTunes online store.